Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Pediatric multiple sclerosis: update in diagnosis and management.
Safety Study of an Immunomodulating Microparticle to Treat Progressive Multiple Sclerosis
Commentary on "Possible induction of acute disseminated encephalomyelitis (ADEM)-like demyelinating illness by intrathecal mesenchymal stem cell injection"
Acute exacerbation of multiple sclerosis presenting with facial metamorphopsia and palinopsia.
Neuropathologic correlates of magnetic resonance imaging in multiple sclerosis.
Disruption of melatonin circadian rhythm production is related to multiple sclerosis severity: A preliminary study.
Tetrahydrocannabinol
Effects of IFN-beta, leptin and simvastatin on LIF secretion by T lymphocytes of MS patients and healthy controls.
Anti-JC virus antibody titres increase over time with natalizumab treatment.
Pulmonary Hypertension and Multiple Sclerosis - Coincidence or Association?
Dendritic cells and multiple sclerosis: disease, tolerance and therapy.
Erythropoietin and autoimmune neuroinflammation: lessons from experimental autoimmune encephalomyelitis and experimental autoimmune neuritis.
Theranostic implications of nanotechnology in multiple sclerosis: a future perspective.
Long-Term Neurocognitive, Psychosocial, and Magnetic Resonance Imaging Outcomes in Pediatric-Onset Acute Disseminated Encephalomyelitis.
Network Analysis of Randomized Controlled Trials in Multiple Sclerosis.
Homonymous hemimacular thinning: a unique presentation of optic tract injury in neuromyelitis optica.
Ethical challenges in paediatric clinical trials in multiple sclerosis.
Changes in Th17 and regulatory T cells after fingolimod initiation to treat multiple sclerosis.
Relapsing-Remitting Central Nervous System Autoimmunity Mediated by GFAP-Specific CD8 T Cells.
Reply to letter to the editor: "JC viremia and multiple sclerosis" by Focosi et al.
Utilization of brain MRI with focus on cerebral lesions and atrophy to better characterize MS phenotypes.
Evidence linking HHV-6 with multiple sclerosis: an update.
[Neuromyelitis optica and anti-aquaporin 4 antibody].
Multiple rodent models and behavioral measures reveal unexpected responses to FTY720 and DMF in experimental autoimmune encephalomyelitis.
Changes of synapses in experimental autoimmune encephalomyelitis by using Fasudil.
Pages
« first
‹ previous
…
216
217
218
219
220
221
222
223
224
…
next ›
last »